176 related articles for article (PubMed ID: 36009404)
1. A Targeted Proteomics Approach for Screening Serum Biomarkers Observed in the Early Stage of Type I Endometrial Cancer.
Ura B; Capaci V; Aloisio M; Di Lorenzo G; Romano F; Ricci G; Monasta L
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009404
[TBL] [Abstract][Full Text] [Related]
2. A Label-Free Proteomic Approach for the Identification of Biomarkers in the Exosome of Endometrial Cancer Serum.
Sommella E; Capaci V; Aloisio M; Salviati E; Campiglia P; Molinario G; Licastro D; Di Lorenzo G; Romano F; Ricci G; Monasta L; Ura B
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551747
[TBL] [Abstract][Full Text] [Related]
3. A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer.
Enroth S; Berggrund M; Lycke M; Lundberg M; Assarsson E; Olovsson M; Stålberg K; Sundfeldt K; Gyllensten U
Clin Proteomics; 2018; 15():38. PubMed ID: 30519148
[TBL] [Abstract][Full Text] [Related]
4. Targeted proteomics-derived biomarker profile develops a multi-protein classifier in liquid biopsies for early detection of esophageal squamous cell carcinoma from a population-based case-control study.
Yang X; Suo C; Zhang T; Yin X; Man J; Yuan Z; Yu J; Jin L; Chen X; Lu M; Ye W
Biomark Res; 2021 Feb; 9(1):12. PubMed ID: 33597040
[TBL] [Abstract][Full Text] [Related]
5. Two Dimensional-Difference in Gel Electrophoresis (2D-DIGE) Proteomic Approach for the Identification of Biomarkers in Endometrial Cancer Serum.
Ura B; Biffi S; Monasta L; Arrigoni G; Battisti I; Di Lorenzo G; Romano F; Aloisio M; Celsi F; Addobbati R; Valle F; Rampazzo E; Brucale M; Ridolfi A; Licastro D; Ricci G
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298850
[TBL] [Abstract][Full Text] [Related]
6. Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin.
Yurkovetsky Z; Ta'asan S; Skates S; Rand A; Lomakin A; Linkov F; Marrangoni A; Velikokhatnaya L; Winans M; Gorelik E; Maxwell GL; Lu K; Lokshin A
Gynecol Oncol; 2007 Oct; 107(1):58-65. PubMed ID: 17659325
[TBL] [Abstract][Full Text] [Related]
7. Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial.
Tarney CM; Wang G; Bateman NW; Conrads KA; Zhou M; Hood BL; Loffredo J; Tian C; Darcy KM; Hamilton CA; Casablanca Y; Lokshin A; Conrads TP; Maxwell GL
Am J Obstet Gynecol; 2019 Nov; 221(5):472.e1-472.e10. PubMed ID: 31279844
[TBL] [Abstract][Full Text] [Related]
8. A serum lipidomics study for the identification of specific biomarkers for endometrial polyps to distinguish them from endometrial cancer or hyperplasia.
Yan X; Zhao W; Wei J; Yao Y; Sun G; Wang L; Zhang W; Chen S; Zhou W; Zhao H; Li X; Xiao Y; Li Y
Int J Cancer; 2022 May; 150(9):1549-1559. PubMed ID: 35076938
[TBL] [Abstract][Full Text] [Related]
9. Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples.
Martinez-Garcia E; Lesur A; Devis L; Campos A; Cabrera S; van Oostrum J; Matias-Guiu X; Gil-Moreno A; Reventos J; Colas E; Domon B
Oncotarget; 2016 Aug; 7(33):53102-53115. PubMed ID: 27447978
[TBL] [Abstract][Full Text] [Related]
10. Metabolomic prediction of endometrial cancer.
Bahado-Singh RO; Lugade A; Field J; Al-Wahab Z; Han B; Mandal R; Bjorndahl TC; Turkoglu O; Graham SF; Wishart D; Odunsi K
Metabolomics; 2017 Dec; 14(1):6. PubMed ID: 30830361
[TBL] [Abstract][Full Text] [Related]
11. Targeted Proteomics Identifies Proteomic Signatures in Liquid Biopsies of the Endometrium to Diagnose Endometrial Cancer and Assist in the Prediction of the Optimal Surgical Treatment.
Martinez-Garcia E; Lesur A; Devis L; Cabrera S; Matias-Guiu X; Hirschfeld M; Asberger J; van Oostrum J; Casares de Cal MLÁ; Gómez-Tato A; Reventos J; Domon B; Colas E; Gil-Moreno A
Clin Cancer Res; 2017 Nov; 23(21):6458-6467. PubMed ID: 28790116
[No Abstract] [Full Text] [Related]
12. Identification of Novel Predictive Biomarkers for Endometrial Malignancies:
Ayakannu T; Taylor AH; Marczylo TH; Maccarrone M; Konje JC
Front Oncol; 2019; 9():430. PubMed ID: 31245282
[No Abstract] [Full Text] [Related]
13. A multiplex platform for the identification of ovarian cancer biomarkers.
Boylan KLM; Geschwind K; Koopmeiners JS; Geller MA; Starr TK; Skubitz APN
Clin Proteomics; 2017; 14():34. PubMed ID: 29051715
[TBL] [Abstract][Full Text] [Related]
14. CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis.
Torres A; Pac-Sosińska M; Wiktor K; Paszkowski T; Maciejewski R; Torres K
BMC Cancer; 2019 Apr; 19(1):401. PubMed ID: 31035965
[TBL] [Abstract][Full Text] [Related]
15. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.
Li J; Zhang Z; Rosenzweig J; Wang YY; Chan DW
Clin Chem; 2002 Aug; 48(8):1296-304. PubMed ID: 12142387
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive serum proteomic analysis in early endometrial cancer.
Uyar DS; Huang YW; Chesnik MA; Doan NB; Mirza SP
J Proteomics; 2021 Mar; 234():104099. PubMed ID: 33412313
[TBL] [Abstract][Full Text] [Related]
17. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
Lai J; Xu T; Yang H
BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
[TBL] [Abstract][Full Text] [Related]
18. Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus.
Moore RG; Brown AK; Miller MC; Badgwell D; Lu Z; Allard WJ; Granai CO; Bast RC; Lu K
Gynecol Oncol; 2008 Aug; 110(2):196-201. PubMed ID: 18495222
[TBL] [Abstract][Full Text] [Related]
19. Advances in endometrial cancer protein biomarkers for use in the clinic.
Martinez-Garcia E; Lopez-Gil C; Campoy I; Vallve J; Coll E; Cabrera S; Ramon Y Cajal S; Matias-Guiu X; Van Oostrum J; Reventos J; Gil-Moreno A; Colas E
Expert Rev Proteomics; 2018 Jan; 15(1):81-99. PubMed ID: 29183259
[TBL] [Abstract][Full Text] [Related]
20. Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection.
Fredolini C; Pathak KV; Paris L; Chapple KM; Tsantilas KA; Rosenow M; Tegeler TJ; Garcia-Mansfield K; Tamburro D; Zhou W; Russo P; Massarut S; Facchiano F; Belluco C; De Maria R; Garaci E; Liotta L; Petricoin EF; Pirrotte P
Breast Cancer Res; 2020 Dec; 22(1):135. PubMed ID: 33267867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
